Midland Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Hold
5,774
0.02% 134
2026
Q1
$350K Sell
5,774
-952
-14% -$55.5K 0.02% 126
2025
Q4
$363K Sell
6,726
-1,655
-20% -$79.6K 0.02% 125
2025
Q3
$378K Sell
8,381
-2,572
-23% -$120K 0.02% 132
2025
Q2
$507K Sell
10,953
-2,142
-16% -$105K 0.03% 119
2025
Q1
$799K Sell
13,095
-986
-7% -$57.5K 0.05% 90
2024
Q4
$796K Sell
14,081
-1,251
-8% -$69.9K 0.05% 94
2024
Q3
$793K Sell
15,332
-215
-1% -$10.1K 0.05% 111
2024
Q2
$646K Sell
15,547
-877
-5% -$39.2K 0.04% 120
2024
Q1
$891K Buy
16,424
+574
+4% +$29.2K 0.05% 97
2023
Q4
$813K Buy
+15,850
New +$832K 0.06% 103

Other funds holding BMY

Midland Wealth Advisors's BMY Position: Q2 2026 in Review

Midland Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,774 shares worth $333K. The position accounts for 0.02% of the portfolio, ranked #134.

Midland Wealth Advisors first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $891K in Q1 2024. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Midland Wealth Advisors held 5,774 shares of Bristol-Myers Squibb worth $333K as of Q2 2026.
  • Midland Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Midland Wealth Advisors's portfolio in Q2 2026, its #134 holding.
  • Midland Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Midland Wealth Advisors's Bristol-Myers Squibb position peaked at $891K in Q1 2024.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Midland Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.